Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03947697 · ClinicalTrials.gov registry record · NA

Improving Glycemic Control With Electrical Stimulation

A NA study of Obesity and Overweight, sponsored by University of Texas, El Paso.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03947697: Recruiting NA study of Obesity and Overweight, sponsored by University of Texas, El Paso.

NCT03947697 is a NA study of Obesity and Overweight that is actively recruiting participants, run by University of Texas, El Paso. The registered enrollment target is 60 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03947697, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by University of Texas, El Paso.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=15 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.

Primary Outcome

Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring

Interventions

  • DEVICE Neuromuscular Electrical Stimulation (Sensory)
  • DEVICE Neuromuscular Electrical Stimulation
  • OTHER Resistance Training

Study Locations (1)

Texas

  • University of Texas at El Paso - El Paso

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-08-09
Est. Completion 2027-04-30
Phase NA
University of Texas, El Paso

17 total trials

What NCT03947697 shows while recruiting

NCT03947697 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Neuromuscular Electrical Stimulation (Sensory) is the first listed.

NCT03947697 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03947697 about?

NCT03947697 is a clinical study titled "Improving Glycemic Control With Electrical Stimulation". Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. I...

What is the current status of trial NCT03947697?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-08-09. Estimated completion is 2027-04-30.

What conditions does trial NCT03947697 study?

This clinical trial studies the following conditions: Obesity, Overweight, Insulin Resistance.

What interventions are being tested in trial NCT03947697?

The interventions under investigation include: Neuromuscular Electrical Stimulation (Sensory) (DEVICE), Neuromuscular Electrical Stimulation (DEVICE), Resistance Training (OTHER).

Who is sponsoring clinical trial NCT03947697?

This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03947697 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03947697's enrollment target sits among peer trials

60 642nd of 1053 higher than 374 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03947697, the US trial registry maintained by the National Library of Medicine. NCT03947697 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.